stockrow
Friday 6 November 2026
Export OPK’s income statement to Excel — free account
OPKO Health, Inc.
OPK Healthcare Diagnostics & Research
- Revenue
- −56.9%
- EPS
- −333.3%
- Free cash flow
- −3.40%
- Total debt
- +40.7%
Quarter to September 2026, against a year earlier
1.74
0.01
−0.57%
Follow OPK
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 3 | 2 | 4 |
| (17.14%) | (16.92%) | (5.88%) | (12.23%) | ||
| (10.92%) | (10.69%) | (3.83%) | (7.64%) | ||
ROIC |
(5.91%) | (5.25%) | (2.45%) | (6.72%) | |
Return on Tangible Assets |
(44.33%) | (46.33%) | (17.26%) | (20.80%) | |
Average Days of Receivables |
54.28 | 50.02 | 50.84 | 58.36 | |
Free Cash Flow per Share |
(0.25) | (0.23) | (0.18) | (0.18) | |
Free Cash Flow |
(190.53) | (173.96) | (133.73) | (135.01) | |
Capital Expenditures |
(11.99) | (10.66) | (10.35) | (9.97) | |
| Other line items | |||||
Cash ROIC |
(9.63%) | (9.20%) | (7.30%) | (6.86%) | |
Accounts Receivable Turnover |
5.83 | 6.61 | 6.49 | 5.74 | |
Accounts Payable Turnover |
9.09 | 7.19 | 6.53 | 5.46 | |
Inventory Turnover |
6.54 | 5.80 | 5.43 | 4.67 | |
Average Days of Payables |
37.42 | 43.34 | 52.46 | 64.83 | |
Days of Inventory on Hand |
59.92 | 63.18 | 64.83 | 68.46 | |
Tax Rate |
(0.07) | (0.07) | (0.09) | (0.21) | |
Research and Development Expense of Revenue |
20.44% | 21.06% | 21.30% | 25.38% | |
Selling, General and Administrative Expense of Revenue |
36.75% | 36.57% | 35.01% | 35.26% | |
Share Based Compensation of Revenue |
1.77% | 1.86% | 1.85% | 1.97% | |
Interest Coverage |
(1.08) | (0.97) | (1.07) | (2.71) | |
Operating CF/Net income |
0.79 | 0.77 | 1.69 | 0.84 | |
Depreciation/Fixed assets |
1.31 | 1.31 | 1.26 | 1.33 | |
Capex/Depreciation |
(0.12) | (0.11) | (0.11) | (0.11) | |
Revenue per Share |
0.81 | 0.77 | 0.78 | 0.67 | |
Operating CF per Share |
(0.24) | (0.22) | (0.16) | (0.17) | |
Capex per Share |
(0.02) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 4 Nov 2026